Thrombophilic risk factors and unusual clinical features in three Italian CADASIL patients

European Journal of Neurology

Volumn 11, Issue 11, 2004, Pages 782-787

  Pantoni, Leonardo ^a   Sarti, C ^a   Pescini, F ^a   Bianchi, S ^b   Bartolini, L ^a   Nencini, P ^a   Basile, A M ^a   Lamassa, M ^a   Kalaria, R N ^c   Dotti, M T ^b   Federico, A ^b   Inzitari, D ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Age of onset; Antiphospholipid antibodies; CADASIL; Cortical functions; Homocysteine; Leukoencephalopathy; Lipoprotein(a); Vascular risk factors

Indexed keywords

HOMOCYSTEINE; LIPOPROTEIN A; PHOSPHOLIPID ANTIBODY;

ADULT; AGED; ARTICLE; BRAIN CORTEX; CADASIL; CASE REPORT; CLINICAL FEATURE; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; DEMENTIA; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIA; HYPERTENSION; LEUKOENCEPHALOPATHY; MIGRAINE; MOOD DISORDER; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRIORITY JOURNAL; RISK FACTOR; STROKE; THROMBOPHILIA;

AGED; BRAIN; CADASIL; CEREBROVASCULAR DISORDERS; FEMALE; HUMANS; ITALY; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; RISK FACTORS; THROMBOPHILIA;

EID: 9344252203     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2004.00915.x     Document Type: Article

References (34)

1. Auer DP, Putz B, Gossl C, Elbel G, Gasser T, Dichgans M (2001). Differential lesion patterns in CADASIL and sporadic subcortical arteriosclerotic encephalopathy: MR imaging study with statistical parametric group comparison. Radiology 218:443-451.
2. Baudrimont M, Dubas F, Joutel A, Tournier-Lasserve E, Bousser MG (1993). Autosomal dominant leukoencephalopathy and subcortical ischemic stroke. A clinicopathological study. Stroke 24:122-125.
3. van den Berg M, Boers GHJ, Franken DG et al. (1995). Hyperhomocysteinemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease. Eur J Clin Invest 25:176-181.
4. Bertsch T, Mielke O, Holy S et al. (2001). Homocysteine in cerebrovascular disease: an independent risk factor for subcortical vascular encephalopathy. Clin Chem Lab Med 39:721-724.
5. Bienvenu T, Ankri A, Chadefaux B, Montalescot G, Kamoun P (1993). Elevated total plasma homocysteine, a risk factor for thrombosis: relation to coagulation and fibrinolytic parameters. Thromb Res 70:123-129.
6. Caronti B, Calandriello L, Francia A et al. (1998). Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL). Neuropathological and in vitro studies of abnormal elastogenesis. Acta Neurol Scand 98:259-267.
7. Chabriat H, Vahedi K, Iba-Zizen MT et al. (1995). Clinical spectrum of CADASIL: a study of 7 families. Lancet 346:934-939.
8. Chabriat H, Levy C, Taillia H et al. (1998). Patterns of MRI lesions in CADASIL. Neurology 51:452-457.
9. Desmond DW, Moroney JT, Lynch T, Chan S, Chin SS, Mohr JP (1999). The natural history of CADASIL: a pooled analysis of previously published cases. Stroke 30:1230-1233.
10. Dichgans M (2002). Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Phenotypic and mutational spectrum. J Neurol Sci 203-204:77-80.
11. Dichgans M, Mayer M, Uttner I et al. (1998). The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol 44:731-739.
12. Feuerhake F, Volk B, Ostertag CB et al. (2002). Reversible coma with raised intracranial pressure: an unusual clinical manifestation of CADASIL. Acta Neuropathol (Berl) 103:188-192.
13. Flemming KD, Nguyen TT, Abu-Lebdeh HS et al. (2001). Hyperhomocysteinemia in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Mayo Clin Proc 76:1213-1218.
14. Hogervorst E, Ribeiro HM, Molyneux A, Budge M, Smith AD (2002). Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. Arch Neurol 59:787-793.
15. Joutel A, Corpechot C, Ducros A et al. (1996). Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383:707-710.
16. Kalimo H, Ruchoux MM, Viitanen M, Kalaria RN (2002). CADASIL: a common form of hereditary arteriopathy causing brain infarcts and dementia. Brain Pathol 12:371-384.
17. Korczyn AD (2002). Homocysteine, stroke, and dementia. Stroke 33:2343-2344.
18. Le Ber I, Carluer L, Derache N, Lalevee C, Ledoze F, Defer GL (2002). Unusual presentation of CADASIL with reversible coma and confusion. Neurology 59:1115-1116.
19. Lentz SR, Sadler JE (1991). Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. J Clin Invest 88:1906-1914.
20. Levine SR, Brey RL, Sawaya KL et al. (1995). Recurrent stroke and thrombo-occlusive events in the antiphospholipid syndrome. Ann Neurol 38:119-124.
21. Markus HS, Martin RJ, Simpson MA et al. (2002). Diagnostic strategies in CADASIL. Neurology 59:1134-1138.
22. McIlroy SP, Dynan KB, Lawson JT, Patterson CC, Passmore AP (2002). Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke 33:2351-2356.
23. Mielke O, Fassbender K, Bertsch T, Aufenanger J, Hennerici M (1998). Lipoprotein(a) [Lp(a)] in subtypes of cerebrovascular disease: evidence for a role as an independent risk factor in subcortical vascular encephalopathy (SVE). Cerebrovasc Dis 8(Suppl.4):103.
24. O'Sullivan M, Jarosz JM, Martin RJ, Deasy N, Powell JF, Markus HS (2001). MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology 56:628-634.
25. Prins ND, den Heijer T, Hofman A et al. (2002). Homocysteine and cognitive function in the elderly. The Rotterdam Scan Study. Neurology 59:1375-1380.
26. Ridker PM, Stampfer MJ, Hennekens CH (1995). Plasma concentration of lipoprotein(a) and the risk of future stroke. JAMA 273:1269-1273.
27. Ruchoux MM, Maurage CA (1997). CADASIL: cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. J Neuropathol Exp Neurol 56:947-964.
28. Ruchoux MM, Guerouaou D, Vandenhaute B, Pruvo JP, Vermersch P, Leys D (1995). Systemic vascular smooth muscle cell impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Acta Neuropathol (Berl) 89:500-512.
29. Schon F, Martin RJ, Prevett M, Clough C, Enevoldson TP, Markus HS (2003). 'CADASIL coma': an underdiagnosed acute encephalopathy. J Neurol Neurosurg Psychiatry 74:249-252.
30. Selhub J, Jacques PF, Bostom AG et al. (1995). Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 332:286-291.
31. Seshadri S, Beiser A, Selhub J et al. (2002). Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 346:476-483.
32. Stamler JS, Osborne JA, Jaraki O et al. (1993). Adverse vascular effects of homocysteine are modulated by endothelial-derived relaxing factor and related oxides of nitrogen. J Clin Invest 91:308-318.
33. Vermeer SE, van Dijk EJ, Koudstaal PJ et al. (2002). Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study. Ann Neurol 51:285-289.
34. Yousry TA, Seelos K, Mayer M et al. (1999). Characteristic MR lesion pattern and correlation of T1 and T2 lesion volume with neurologic and neuropsychological findings in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). AJNR Am J Neuroradiol 20:91-100.